Mode
Text Size
Log in / Sign up
N/A Completed N=195 Randomized Single-blind Treatment

Effectiveness of Tailored Activity Pacing for Symptomatic Osteoarthritis

Source: ClinicalTrials.gov NCT01192516 ↗
Enrolled (actual)
195
Serious AEs
0.0%
Results posted
Mar 2015
Primary outcomePrimary: Fatigue- Brief Fatigue Inventory (BFI) — 3.06; 3.18; 2.70 units on a scale

Summary

The primary objective of this project is to examine effectiveness of a tailored pacing intervention on fatigue, pain, and physical function compared to general pacing intervention and usual care groups. A secondary objective is to evaluate the natural history of symptoms and physical disability over time among people with knee and hip osteoarthritis.

Outcome Measures

OutcomeResultp-value
PRIMARY
Fatigue- Brief Fatigue Inventory (BFI)
3.06; 3.18; 2.70 —
PRIMARY
Fatigue-BFI
3.30; 2.90; 2.83 .85
PRIMARY
Pain- Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
8.23; 8.19; 8.27 —
PRIMARY
Pain- WOMAC
7.63; 7.33; 6.68 .06
SECONDARY
Physical Function- Six Minute Walk
1225.4; 1264.3; 1222.4 .36

Eligibility Criteria

Inclusion Criteria

  • Age of 50 years and older
  • Reported pain for at least 3 months
  • Mild-moderate pain severity according to the WOMAC pain scale
  • Radiographic evidence of knee or hip osteoarthritis (Kellgren-Lawrence score of 2 in at least one joint)
  • Community-dwelling (i.e. own home, apartment, senior residence)
  • Ambulatory with or without a cane or walker
  • Adequate cognition to complete study activities (score of 5 on the 6-Item Screener)
  • Ability to use the Actiwatch-S (Phillips-Respironics, Mini-Mitter, Bend OR)accelerometer to record symptoms and activity patterns (ascertained by completion of a learning module specific to the use of the device in this study)
  • English-speaking

Exclusion Criteria

  • Self-reported medical history of conditions with pain and/or fatigue as a known and marked symptom (e.g multiple sclerosis, rheumatoid arthritis)
  • Medically unstable (e.g. acute conditions or acute presentations of chronic conditions)
  • Anemia (hemoglobin of 5.5 mg/dl)
  • 2 or more days of complete bed rest within the last month
  • Limb hemiplegia or amputation
  • Arthroscopic procedure within the previous 2 months
  • Joint injection within the previous 3 months
  • Total or partial joint replacement within the previous 6 months
  • Self-reported illness or conditions that impair cooperation with the study team or ability to complete study procedures
  • Current enrollee in physical or occupational therapy for symptoms associated with osteoarthritis
  • Current attendance or attendance within the previous year in a cognitive behavioral therapy program or other self-management program that includes activity pacing instruction
  • Any other unforeseen exclusion criteria that, by the opinion of the study personnel, would make the participant unable to safely or effectively complete the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01192516). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search